Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Mosnier

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Vaccines|November 27, 2021
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert ConsensusRaul Ortiz de Lejarazu-Leonardo, Emanuele Montomoli, Radek Wojcik, et al.
Antiviral Research|August 23, 2012
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infectionsVanessa Escuret, Catherine Cornu, Florent Boutitie, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 20, 2017
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014Jean-Sebastien Casalegno, Daniel Eibach, Martine Valette, et al.
The Journal of Clinical Investigation|June 10, 2014
Characterization of pandemic influenza immune memory signature after vaccination or infectionOlivia Bonduelle, Fabrice Carrat, Charles-Edouard Luyt, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2024
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-2022 influenza seasonHélène Bricout, Marie-Cécile Levant, Nada Assi, et al.
Influenza and Other Respiratory Viruses|November 17, 2025
Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 SeasonHélène Bricout, Marie-Cécile Levant, Pascal Crépey, et al.
Plos Medicine|November 13, 2010
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialXavier Duval, Sylvie van der Werf, Thierry Blanchon, et al.
Influenza and Other Respiratory Viruses|December 6, 2021
A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United KingdomThierry Rigoine de Fougerolles, Joan Puig-Barbera, George Kassianos, et al.
Germs|January 8, 2025
Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024"George Kassianos, Rok Civljak, Gerrit Adrianus van Essen, et al.
Plos Medicine|March 8, 2011
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studyMarta Valenciano, Esther Kissling, Jean-Marie Cohen, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Vaccines|November 27, 2021
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert ConsensusRaul Ortiz de Lejarazu-Leonardo, Emanuele Montomoli, Radek Wojcik, et al.
Antiviral Research|August 23, 2012
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infectionsVanessa Escuret, Catherine Cornu, Florent Boutitie, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 20, 2017
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014Jean-Sebastien Casalegno, Daniel Eibach, Martine Valette, et al.
The Journal of Clinical Investigation|June 10, 2014
Characterization of pandemic influenza immune memory signature after vaccination or infectionOlivia Bonduelle, Fabrice Carrat, Charles-Edouard Luyt, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2024
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-2022 influenza seasonHélène Bricout, Marie-Cécile Levant, Nada Assi, et al.
Influenza and Other Respiratory Viruses|November 17, 2025
Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 SeasonHélène Bricout, Marie-Cécile Levant, Pascal Crépey, et al.
Plos Medicine|November 13, 2010
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialXavier Duval, Sylvie van der Werf, Thierry Blanchon, et al.
Influenza and Other Respiratory Viruses|December 6, 2021
A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United KingdomThierry Rigoine de Fougerolles, Joan Puig-Barbera, George Kassianos, et al.
Germs|January 8, 2025
Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024"George Kassianos, Rok Civljak, Gerrit Adrianus van Essen, et al.
Plos Medicine|March 8, 2011
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studyMarta Valenciano, Esther Kissling, Jean-Marie Cohen, et al.
Pageof 5